Illumina accelerates microbiome research in Australia

US-based Illumina, Inc., the global leader in DNA sequencing and array-based technologies, has announced that it has united with leaders in precision gut microbiome science Microba Life Sciences, based in Australia, to advance understanding of the human gut microbiome in human health and disease. The partnership will bring together Microba’s high-quality proprietary gut microbiome analysis platform with Illumina’s revolutionising Next Generation Sequencing tools to generate the accurate metagenomic data researchers require to make new discoveries. Focusing activities in Asia Pacific and Japan, the duo will work together to enable research studies that reveal connections between the microbiome and human health from mental health and Parkinson’s disease to nutrition and sleep.